TIM
BHC icon

Tevis Investment Management’s Bausch Health BHC Stock Holding History

Tevis Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-169
Closed -$4K – 483
2022
Q1 		$4K Hold
169
– – ﹤0.01% 440
2021
Q4 		$5K Buy
+169
New +$4.52K ﹤0.01% 483

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Tevis Investment Management's BHC Position: Q2 2022 in Review

Tevis Investment Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 169 shares — an estimated $4K sold.

Tevis Investment Management first reported a position in BHC in Q4 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Tevis Investment Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Tevis Investment Management sold 169 Bausch Health shares in Q2 2022, an estimated $4K.
  • Tevis Investment Management first reported a position in Bausch Health in Q4 2021 and held it in 2 quarters.
  • Tevis Investment Management's Bausch Health position peaked at $5K in Q4 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Tevis Investment Management's 13F filing for Q2 2022, filed 8 Aug 2022.